Cargando…
Draft Genome Sequence of Proteus mirabilis NO-051/03, Representative of a Multidrug-Resistant Clone Spreading in Europe and Expressing the CMY-16 AmpC-Type β-Lactamase
Proteus mirabilis NO-051/03, representative of a multidrug-resistant clone expressing the CMY-16 AmpC-type β-lactamase and circulating in Europe since 2003, was sequenced by a MiSeq platform using a paired-end approach. The genome was assembled in 100 scaffolds with a total length of 4,197,318 bp. A...
Autores principales: | D’Andrea, Marco Maria, Giani, Tommaso, Henrici De Angelis, Lucia, Ciacci, Nagaia, Gniadkowski, Marek, Miriagou, Vivi, Torricelli, Francesca, Rossolini, Gian Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751317/ https://www.ncbi.nlm.nih.gov/pubmed/26868393 http://dx.doi.org/10.1128/genomeA.01702-15 |
Ejemplares similares
-
Prevalence of extended-spectrum β-lactamases, AmpC, and carbapenemases in Proteus mirabilis clinical isolates
por: Shaaban, Mona, et al.
Publicado: (2022) -
Identification of emergent bla(CMY-2)-carrying Proteus mirabilis lineages by whole-genome sequencing
por: Mac Aogáin, M., et al.
Publicado: (2015) -
Complete Genome Sequence of the First KPC-Type Carbapenemase-Positive Proteus mirabilis Strain from a Bloodstream Infection
por: Di Pilato, Vincenzo, et al.
Publicado: (2016) -
Pathogenic Factors Correlate With Antimicrobial Resistance Among Clinical Proteus mirabilis Strains
por: Filipiak, Aneta, et al.
Publicado: (2020) -
The Assessment of Proteus mirabilis Susceptibility to Ceftazidime and Ciprofloxacin and the Impact of These Antibiotics at Subinhibitory Concentrations on Proteus mirabilis Biofilms
por: Kwiecińska-Piróg, Joanna, et al.
Publicado: (2013)